Literature DB >> 1740658

Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.

A Vacca1, M P Felli, A R Farina, S Martinotti, M Maroder, I Screpanti, D Meco, E Petrangeli, L Frati, A Gulino.   

Abstract

The immunosuppressant hormone dexamethasone (Dex) interferes with T cell-specific signals activating the enhancer sequences directing interleukin 2 (IL-2) transcription. We report that the Dex-dependent downregulation of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and calcium ionophore-induced activity of the IL-2 enhancer are mediated by glucocorticoid receptor (GR) via a process that requires intact NH2- and COOH-terminal and DNA-binding domains. Functional analysis of chloramphenicol acetyltransferase (CAT) vectors containing internal deletions of the -317 to +47 bp IL-2 enhancer showed that the GR-responsive elements mapped to regions containing nuclear factor of activated T cells protein (NFAT) (-279 to -263 bp) and AP-1 (-160 to -150 bp) motifs. The AP-1 motif binds TPA and calcium ionophore-induced nuclear factor(s) containing fos protein. TPA and calcium ionophore-induced transcriptional activation of homo-oligomers of the NFAT element were not inhibited by Dex, while AP-1 motif concatemers were not stimulated by TPA and calcium ionophore. When combined, NFAT and AP-1 motifs significantly synergized in directing CAT transcription. Such a synergism was impaired by specific mutations affecting the trans-acting factor binding to either NFAT or AP-1 motifs. In spite of the lack of hormone regulation of isolated cis elements, TPA/calcium ionophore-mediated activation of CAT vectors containing a combination of the NFAT and the AP-1 motifs became suppressible by Dex. Our results show that the IL-2-AP-1 motif confers GR sensitivity to a flanking region containing a NFAT element and suggest that synergistic cooperativity between the NFAT and AP-1 sites allows GR to mediate the Dex inhibition of IL-2 gene transcription. Therefore, a Dex-modulated second level of IL-2 enhancer regulation, based on a combinatorial modular interplay, appears to be present.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740658      PMCID: PMC2119143          DOI: 10.1084/jem.175.3.637

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

Review 1.  Modularity in promoters and enhancers.

Authors:  W S Dynan
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

3.  Enhancement of c-erbA proto-oncogene expression by glucocorticoid hormones in S49.1 lymphoma cells.

Authors:  M Maroder; A Vacca; I Screpanti; E Petrangeli; L Frati; A Gulino
Journal:  Biochim Biophys Acta       Date:  1989-11-02

4.  Transcriptional activity of the gibbon ape leukemia virus in the interleukin 2 gene of MLA 144 cells.

Authors:  N J Holbrook; A Gulino; D Durand; Y Lin; G R Crabtree
Journal:  Virology       Date:  1987-07       Impact factor: 3.616

5.  The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.

Authors:  M J Tocci; D A Matkovich; K A Collier; P Kwok; F Dumont; S Lin; S Degudicibus; J J Siekierka; J Chin; N I Hutchinson
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

6.  Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers.

Authors:  J P Quinn; M Takimoto; M Iadarola; N Holbrook; D Levens
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

7.  The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence.

Authors:  I Davidson; J H Xiao; R Rosales; A Staub; P Chambon
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

8.  Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene.

Authors:  H Shibuya; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

9.  Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression.

Authors:  B Hoyos; D W Ballard; E Böhnlein; M Siekevitz; W C Greene
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

10.  Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes.

Authors:  E Serfling; R Barthelmäs; I Pfeuffer; B Schenk; S Zarius; R Swoboda; F Mercurio; M Karin
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  34 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06

Review 3.  Immunosuppressive drug therapy.

Authors:  Choli Hartono; Thangamani Muthukumar; Manikkam Suthanthiran
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 4.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

5.  Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.

Authors:  Michael W Harr; Yiping Rong; Martin D Bootman; H Llewelyn Roderick; Clark W Distelhorst
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

Review 6.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

7.  Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors.

Authors:  J Van Wauwe; F Aerts; H Walter; M de Boer
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

Review 8.  Glucocorticoids in T cell apoptosis and function.

Authors:  M J Herold; K G McPherson; H M Reichardt
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

9.  Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.

Authors:  Hazem Khalaf; Jana Jass; Per-Erik Olsson
Journal:  BMC Immunol       Date:  2010-05-27       Impact factor: 3.615

10.  Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.

Authors:  M Costas; T Trapp; M P Pereda; J Sauer; R Rupprecht; V E Nahmod; J M Reul; F Holsboer; E Arzt
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.